Sponsored Content
Phenylketonuria (PKU) is a serious metabolic disorder caused by a deficiency in the enzyme phenylalanine hydroxylase. This deficiency leads to the accumulation of phenylalanine in the blood, which can cause severe neurological damage if not managed properly. Early detection of PKU is critical, and this is where phenylalanine dehydrogenase plays a vital role.
PKU is an inherited condition that, if left untreated, can result in intellectual disability, developmental delays, and behavioural problems. The disorder stems from the body's inability to convert phenylalanine, an essential amino acid, into tyrosine due to a defective or missing phenylalanine hydroxylase enzyme. This metabolic blockage causes phenylalanine to build up to toxic levels in the blood.
Early diagnosis is essential for preventing the detrimental effects of PKU. Newborns are routinely screened for PKU through blood tests that measure phenylalanine levels. This is where phenylalanine dehydrogenase (PheDH) becomes indispensable.
The Role of Phenylalanine Dehydrogenase
Phenylalanine dehydrogenase is an enzyme that catalyses the oxidative deamination of phenylalanine, converting it into phenylpyruvate. This reaction also involves the conversion of NAD+ (Nicotinamide adenine dinucleotide) to NADH. This biochemical property of PheDH is harnessed in diagnostic kits to detect elevated levels of phenylalanine.
The Importance of Early Detection
The integration of phenylalanine dehydrogenase in diagnostic kits has revolutionised the early detection of PKU. Early diagnosis enables immediate dietary intervention, which is crucial in preventing the severe neurological damage associated with the disorder. By adhering to a low-phenylalanine diet, individuals with PKU can lead normal, healthy lives.
Phenylalanine dehydrogenase plays a pivotal role in the effective screening and early detection of phenylketonuria. Its ability to catalyse the conversion of phenylalanine and facilitate accurate measurement of its levels in the blood makes it an invaluable tool in neonatal care. As the industry continues to advance its understanding and technology, the use of enzymes like PheDH in diagnostic applications will remain a cornerstone of early disease detection and management.

23 Feb 2026
PharmaLinea, a Slovenian developer and manufacturer of private label food supplements, has announced the completion of a clinical study evaluating its finished formulation for iron deficiency.
Read more
12 Feb 2026
Gentle and effective: magnesium bisglycinate is setting a new standard. Through its LomaChelateX® brand, Dr. Paul Lohmann® delivers magnesium bisglycinate and a broad range of fully reacted mineral bisglycinates made in Germany.
Read more
22 Jan 2026
The global leader in fucoidan science, Marinova Pty Ltd, reported record annual fucoidan production for 2025. The company's total production volume has more than doubled over the past three years.
Read more
6 Jan 2026
HYDERABAD, December 20, 2025 – India’s Prime Minister Mr. Narendra Modi, alongside WHO Director-General Dr. Tedros Adhanom Ghebreyesus, released a commemorative postal stamp honoring ashwagandha at the recently concluded Second WHO Global Traditional...
Read more
22 Dec 2025
PharmaLinea held its first-ever NutraLoop™ Summit this December. The virtual event featured 12 speakers from companies such as IQVIA, NHCO, Radicle Science, and BeyondBrands, who provided comprehensive insights across the scientific and commercia...
Read more
11 Dec 2025
Royal FrieslandCampina N.V. intends to acquire Wisconsin Whey Protein, a respected producer of whey protein isolates in the United States. Wisconsin Whey Protein will become part of FrieslandCampina Ingredients, a global leader in proteins and prebioti...
Read more
11 Dec 2025
Kaiseraugst (Switzerland), Maastricht (Netherlands), December 5, 2025 dsm-firmenich, innovators in nutrition, health, and beauty, announces ‘Frosted Star Anise’ as its Flavor of the Year for 2026. This...
Read more
11 Dec 2025
Montvale, New Jersey, (10 December, 2025) – Balchem, a leading global manufacturer of specialty ingredients for human nutrition and health, is pleased to announce the development of a new, high-capacity man...
Read more
4 Dec 2025
Marinova has been named Australia's most outstanding contributor to international health in the nation's prestigious Australian Export Awards.
Read more
1 Dec 2025
Prayon inaugurates its new SHMP production unit in Engis, a major investment that strengthens its position in the food and technical phosphates market
Read more